BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:00 PM
 | 
Jul 22, 2009
 |  BC Extra  |  Politics & Policy

Eshoo drafts biosimilars amendment

Rep. Anna Eshoo (D-Calif.) has drafted an amendment to the America's Affordable Health Choices Act of 2009 (H.R. 3200) that would provide 12 years of market exclusivity for pioneer biologics. It also would provide an additional six months of exclusivity for conducting FDA-requested pediatric trials.

Read the full 209 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >